Nu Skin Forecasts Q3 EPS 25c-35c, Revenue $360M-$390M
ByAinvest
Saturday, Aug 9, 2025 12:40 am ET1min read
NUS--
The company's Q3 2025 EPS guidance represents a 16% increase from the second quarter's EPS of $0.21, suggesting a potential rebound in earnings. The revenue projection for Q3 2025 is in line with the company's Q2 2025 performance, indicating stable growth expectations. Nu Skin's revenue guidance for the third quarter is also slightly above the analyst consensus of $366.10 million.
Nu Skin's financial health score is rated as "fair performance" by InvestingPro, reflecting the company's mixed earnings performance in recent quarters. The company's stock price has shown resilience, trading at 9 times the next 12-month earnings, down from a P/E of 7 three months ago [2].
Investors should closely monitor Nu Skin's earnings performance in the coming quarters, as the company's strategic initiatives, such as the upcoming launch of the Prism.io wellness platform in Q4 2025, could significantly impact future growth prospects [3].
References:
[1] https://www.investing.com/news/earnings/nu-skin-earnings-missed-by-004-revenue-topped-estimates-4178514
[2] https://www.marketscreener.com/news/nu-skin-reports-rise-in-q2-adjusted-net-income-ce7c5edcdb88fe27
[3] https://www.investing.com/news/transcripts/earnings-call-transcript-nu-skin-q2-2025-reports-mixed-results-stock-rebounds-93CH-4179779
Nu Skin expects Q3 EPS to be between 25c and 35c, and revenue to be between $360M and $390M.
Nu Skin Enterprises (NYSE: NUS) has provided its guidance for the third quarter of 2025, with expected earnings per share (EPS) ranging from $0.25 to $0.35 and revenue projected between $360 million and $390 million. The company reported its second-quarter earnings on July 2, 2025, with EPS of $0.21, missing the analyst estimate of $0.25, but revenue of $386.1 million exceeded the consensus estimate of $376.67 million [1].The company's Q3 2025 EPS guidance represents a 16% increase from the second quarter's EPS of $0.21, suggesting a potential rebound in earnings. The revenue projection for Q3 2025 is in line with the company's Q2 2025 performance, indicating stable growth expectations. Nu Skin's revenue guidance for the third quarter is also slightly above the analyst consensus of $366.10 million.
Nu Skin's financial health score is rated as "fair performance" by InvestingPro, reflecting the company's mixed earnings performance in recent quarters. The company's stock price has shown resilience, trading at 9 times the next 12-month earnings, down from a P/E of 7 three months ago [2].
Investors should closely monitor Nu Skin's earnings performance in the coming quarters, as the company's strategic initiatives, such as the upcoming launch of the Prism.io wellness platform in Q4 2025, could significantly impact future growth prospects [3].
References:
[1] https://www.investing.com/news/earnings/nu-skin-earnings-missed-by-004-revenue-topped-estimates-4178514
[2] https://www.marketscreener.com/news/nu-skin-reports-rise-in-q2-adjusted-net-income-ce7c5edcdb88fe27
[3] https://www.investing.com/news/transcripts/earnings-call-transcript-nu-skin-q2-2025-reports-mixed-results-stock-rebounds-93CH-4179779
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet